Pharmaceuticals
Analysis: Senores Pharmaceuticals Ltd
The current section of the “Analysis” series covers Senores Pharmaceuticals Ltd, an Indian pharmaceutical company focusing primarily on the regulated markets of the USA, UK and Canada. The company also has a smaller presence in India and other emerging pharmaceutical markets. Please note that to
Analysis: Titan Biotech Ltd
The current section of the “Analysis” series covers Titan Biotech Ltd, an Indian company engaged in the manufacturing of biotechnology products such as protein hydrolysates, collagen, peptones and dehydrated culture media. Please note that to get maximum benefit from this article, an investor should focus
Analysis: Abbott India Ltd
The current section of the “Analysis” series covers Abbott India Ltd, a part of Abbott Group, USA. The company is a leading pharmaceutical company in India with leading brands like Thyronorm, Digene, Cremafin, Brufen, and Duphaston among many others. To benefit the maximum from this
Analysis: Dr Reddy’s Laboratories Ltd
The current section of the “Analysis” series covers Dr Reddy’s Laboratories Ltd (DRL), a leading Indian pharmaceutical company with global operations across North America, Europe, Russia, South America and the rest of the world. DRL has products in generics, active pharmaceutical ingredients (APIs), custom products,
Analysis: Laurus Labs Ltd
The current section of the “Analysis” series covers Laurus Labs Ltd, an Indian pharmaceutical company focusing on the production of APIs, formulations as well as the custom synthesis of drugs in antiretroviral (HIV), Oncology, Hepatitis-C, Diabetes, Cardiovascular diseases etc. “Analysis” series is an attempt to
How to do Business Analysis of Pharmaceutical Companies
The current article aims to cover the key factors affecting the business model of pharmaceutical (pharma) companies. After reading this article, an investor would be able to differentiate pharmaceutical companies based on the strength of their business model. She would be able to have an
Analysis: NGL Fine Chem Ltd
The current section of the “Analysis” series covers NGL Fine Chem Ltd, an Indian manufacturer of active pharmaceutical ingredients (API) primarily for animal drugs. “Analysis” series is an attempt to share with all the readers, our inputs to the company analysis submitted by readers on
Analysis: Lincoln Pharmaceuticals Ltd
The current section of the “Analysis” series covers Lincoln Pharmaceuticals Ltd, an Indian company manufacturing pharmaceutical formulations. The company sells its products primarily in India and African nations. “Analysis” series is an attempt to share with all the readers, our inputs to the company analysis
Analysis: Marksans Pharma Ltd
The current section of the “Analysis” series covers Marksans Pharma Ltd, an Indian drug manufacturer selling generic drugs primarily in the developed markets of the USA, UK, Europe and Australia. The company has production facilities in Goa, India as well as in the UK and
Analysis: IOL Chemicals and Pharmaceuticals Ltd
The current section of the “Analysis” series covers IOL Chemicals and Pharmaceuticals Ltd, an associate of the Trident Group, India. The company primarily manufactures two products, Ibuprofen and Ethyl Acetate. In addition, the company also deals in active pharmaceutical ingredients (API) and other chemicals. “Analysis”
- Buy/sell recommendations for selected stocks with a crisp investment rationale
- We have selected these stocks after an in-depth financial, business, valuation, and management analysis
“Peaceful Investing” is the result of my experience of more than 15 years in stock markets. It aims to find such stocks, where after investing, an investor may sleep peacefully. If later on, the stock prices increase, then the investor is happy as she is now wealthier. If the stock prices decline, even then the investor is happy as she can now buy more quantity of the selected fundamentally good stocks.
Sign up to get updates
+ Get 12 free e-books on Stock Analysis